Pharmacologic management of cancer pain in rural Minnesota

Leonard Lichtblau; Miles Belgrade; Richard Auld; Thomas E. Elliott

doi:10.1016/S0885-3924(96)00179-0

Pharmacologic management of cancer pain in rural Minnesota

Leonard Lichtblau, Miles Belgrade, Richard Auld, Thomas E. Elliott

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Use of analgesic medications for cancer pain was assessed in six Minnesota communities. In our survey, cancer patients were treated primarily by family practice physicians. Approximately 70% were given one or more analgesics; 84% received a nonsteroidal antiinflammatory drug and 73% received an opioid. Most patients given an antiinflammatory drug received less than the maximal recommended dose for the drug. The most common opioid for cancer pain was oral morphine. Approximately 40% of the patients treated with opioids took the drug only when needed; the remainder took the drug around-the-clock, with or without additional opioids for breakthrough pain. Only 14% of patients who received analgesics received a coanalgesic and only 13% received a nonanalgesic adjuvant. The patterns of analgesic use in these communities corresponded well with accepted principles of cancer pain management: liberal use of opioids, use of oral morphine as the predominant agent, and avoidance of meperidine and opioid agonist/antagonists.

Original language	English (US)
Pages (from-to)	283-289
Number of pages	7
Journal	Journal of Pain and Symptom Management
Volume	12
Issue number	5
DOIs	https://doi.org/10.1016/S0885-3924(96)00179-0
State	Published - Nov 1996
Externally published	Yes

Bibliographical note

Funding Information:
This study was supported by a U.S. Public Health Service R25 grant frum the National Cancer Institute (C&57803), awarded to Thomas E. Elliott, M.D., Principal Investigator. Minnesota Cancer Pain Project. The authors wish to acknowledge David M. Murray, Ph.D., and Barbara Braun. Ph.D., for their assistance in analyzing the data, and the members of Research and Evaluation Committee of the Minnesota Cancer Pai. Initiative and Barbara A. Elliott, Ph.D.. for developing the survey tool used in this report. The authors also thank the patients and their families who were interviewed for this report for their participation in the study.

Keywords

Cancer Pain Initiative
Cancer pain
Minnesota community
NSAID
analgesic adjuvant
opioid

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/S0885-3924(96)00179-0

OpenUrl availability

Full text

Cite this

@article{556e9a8f498f4c5d954dca7352f56e0b,

title = "Pharmacologic management of cancer pain in rural Minnesota",

abstract = "Use of analgesic medications for cancer pain was assessed in six Minnesota communities. In our survey, cancer patients were treated primarily by family practice physicians. Approximately 70% were given one or more analgesics; 84% received a nonsteroidal antiinflammatory drug and 73% received an opioid. Most patients given an antiinflammatory drug received less than the maximal recommended dose for the drug. The most common opioid for cancer pain was oral morphine. Approximately 40% of the patients treated with opioids took the drug only when needed; the remainder took the drug around-the-clock, with or without additional opioids for breakthrough pain. Only 14% of patients who received analgesics received a coanalgesic and only 13% received a nonanalgesic adjuvant. The patterns of analgesic use in these communities corresponded well with accepted principles of cancer pain management: liberal use of opioids, use of oral morphine as the predominant agent, and avoidance of meperidine and opioid agonist/antagonists.",

keywords = "Cancer Pain Initiative, Cancer pain, Minnesota community, NSAID, analgesic adjuvant, opioid",

author = "Leonard Lichtblau and Miles Belgrade and Richard Auld and Elliott, {Thomas E.}",

note = "Funding Information: This study was supported by a U.S. Public Health Service R25 grant frum the National Cancer Institute (C&57803), awarded to Thomas E. Elliott, M.D., Principal Investigator. Minnesota Cancer Pain Project. The authors wish to acknowledge David M. Murray, Ph.D., and Barbara Braun. Ph.D., for their assistance in analyzing the data, and the members of Research and Evaluation Committee of the Minnesota Cancer Pai. Initiative and Barbara A. Elliott, Ph.D.. for developing the survey tool used in this report. The authors also thank the patients and their families who were interviewed for this report for their participation in the study.",

year = "1996",

month = nov,

doi = "10.1016/S0885-3924(96)00179-0",

language = "English (US)",

volume = "12",

pages = "283--289",

journal = "Journal of Pain and Symptom Management",

issn = "0885-3924",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Pharmacologic management of cancer pain in rural Minnesota

AU - Lichtblau, Leonard

AU - Belgrade, Miles

AU - Auld, Richard

AU - Elliott, Thomas E.

N1 - Funding Information: This study was supported by a U.S. Public Health Service R25 grant frum the National Cancer Institute (C&57803), awarded to Thomas E. Elliott, M.D., Principal Investigator. Minnesota Cancer Pain Project. The authors wish to acknowledge David M. Murray, Ph.D., and Barbara Braun. Ph.D., for their assistance in analyzing the data, and the members of Research and Evaluation Committee of the Minnesota Cancer Pai. Initiative and Barbara A. Elliott, Ph.D.. for developing the survey tool used in this report. The authors also thank the patients and their families who were interviewed for this report for their participation in the study.

PY - 1996/11

Y1 - 1996/11

N2 - Use of analgesic medications for cancer pain was assessed in six Minnesota communities. In our survey, cancer patients were treated primarily by family practice physicians. Approximately 70% were given one or more analgesics; 84% received a nonsteroidal antiinflammatory drug and 73% received an opioid. Most patients given an antiinflammatory drug received less than the maximal recommended dose for the drug. The most common opioid for cancer pain was oral morphine. Approximately 40% of the patients treated with opioids took the drug only when needed; the remainder took the drug around-the-clock, with or without additional opioids for breakthrough pain. Only 14% of patients who received analgesics received a coanalgesic and only 13% received a nonanalgesic adjuvant. The patterns of analgesic use in these communities corresponded well with accepted principles of cancer pain management: liberal use of opioids, use of oral morphine as the predominant agent, and avoidance of meperidine and opioid agonist/antagonists.

AB - Use of analgesic medications for cancer pain was assessed in six Minnesota communities. In our survey, cancer patients were treated primarily by family practice physicians. Approximately 70% were given one or more analgesics; 84% received a nonsteroidal antiinflammatory drug and 73% received an opioid. Most patients given an antiinflammatory drug received less than the maximal recommended dose for the drug. The most common opioid for cancer pain was oral morphine. Approximately 40% of the patients treated with opioids took the drug only when needed; the remainder took the drug around-the-clock, with or without additional opioids for breakthrough pain. Only 14% of patients who received analgesics received a coanalgesic and only 13% received a nonanalgesic adjuvant. The patterns of analgesic use in these communities corresponded well with accepted principles of cancer pain management: liberal use of opioids, use of oral morphine as the predominant agent, and avoidance of meperidine and opioid agonist/antagonists.

KW - Cancer Pain Initiative

KW - Cancer pain

KW - Minnesota community

KW - NSAID

KW - analgesic adjuvant

KW - opioid

UR - http://www.scopus.com/inward/record.url?scp=0030296511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030296511&partnerID=8YFLogxK

U2 - 10.1016/S0885-3924(96)00179-0

DO - 10.1016/S0885-3924(96)00179-0

M3 - Article

C2 - 8942123

AN - SCOPUS:0030296511

SN - 0885-3924

VL - 12

SP - 283

EP - 289

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

IS - 5

ER -

Pharmacologic management of cancer pain in rural Minnesota

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this